Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis

Amyloid. 2021 Dec;28(4):267-268. doi: 10.1080/13506129.2021.1904390. Epub 2021 Aug 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloid Neuropathies, Familial* / drug therapy
  • Amyloid Neuropathies, Familial* / genetics
  • Benzoxazoles
  • Humans
  • Prealbumin* / genetics

Substances

  • Benzoxazoles
  • Prealbumin
  • tafamidis